Each film coated tablet contains Obeticholic Acid INN 5 mg.
Obeticholic acid is indicated for the treatment of adultpatients with primary biliary cholangitis (PBC) without cirrhosis or with compensated cirrhosis who do not have evidence of portal hypertension, Either in combination with Ursodeoxycholic Acid (UDCA) with an inadequate response to UDCA or as monotherapy in patients unable to tolerate UDCA
Each film coated tablet contains Obeticholic Acid INN 5 mg.
Obeticholic acid is indicated for the treatment of adultpatients with primary biliary cholangitis (PBC) without cirrhosis or with compensated cirrhosis who do not have evidence of portal hypertension, Either in combination with Ursodeoxycholic Acid (UDCA) with an inadequate response to UDCA or as monotherapy in patients unable to tolerate UDCA
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.